Page results
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Once you have completed treatment for cancer at UCLH you will enter a period of follow-up care. Follow-up is an important way of monitoring your health.
-
This page explains how our plasma cell multidisciplinary team (MDT) will support you during treatmen
-
Information about incentive spirometry (IS) for adults with sickle cell disorder.
-
Information about community sickle cell and thalassaemia services provided via UCLH.
-
Support patients in hospital this Christmas and the staff looking after them by donating to our UCLH Charity Gift of Giving Appeal.
-
A guide to choosing diabetes technology for UCLH patients
-
Our cancer team monitors all urgent, two-week wait, suspected cancer referrals from GPs. All appointments are carefully and systematically monitored to ensure a speedy and efficient patient journey from diagnosis to treatment or discharge.
-
Dr Riaz' clinical practice includes a wide range of radionuclide diagnostic and therapeutic procedures, including conventional Nuclear Medicine imaging, oncologic and non-oncological PET imaging, cardiac PET imaging, and radionuclide therapies for thyroid cancer, prostate cancer and other rare cancers.
-
This page explains who you will meet and what to expect at your appointment with the adolescent gynaecology team at UCLH.
File results
-
FOI/2024/0403 - Risk Policy and corporate risk register
-
FOI/2024/0406 - Staff and patient discrimination complaints in 2021, 2022 and 2023
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0412 - Healthcare travel costs scheme for patients
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0420 - Commercialisation of NHS patient data
-
FOI/2024/0421 - Capital staffing nurses/ approved framework agencies/ escalated rates
-
FOI/2024/0423 - Giant cell arteritis (GCA) patient treatment